In addition, the thyroid stimulating hormone (TSH) level was significantly higher in PTC than in non-cancer control [33], correspondingly, T3 increased, thus the expression of APO C-III was possibly inhibited in PTC patients. The gene discussed is APOC3; the disease is cancer.